Blood‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Blood‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis

Published:2022-07-17 Issue:5 Volume:9 Page:3418-3434
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Jansen Mark¹²^ORCID,Algül Sila³,Bosman Laurens P.²⁴,Michels Michelle⁵,van der Velden Jolanda³,de Boer Rudolf A.⁶,van Tintelen J. Peter¹²,Asselbergs Folkert W.²⁴⁷⁸,Baas Annette F.¹

Affiliation:

1. Department of Genetics, University Medical Center Utrecht Utrecht University Utrecht The Netherlands

2. Netherlands Heart Institute Utrecht The Netherlands

3. Department of Physiology, Amsterdam Cardiovascular Sciences Amsterdam University Medical Center, Vrije Universiteit Amsterdam Amsterdam The Netherlands

4. Department of Cardiology, University Medical Center Utrecht Utrecht University Utrecht The Netherlands

5. Department of Cardiology Thoraxcenter, Erasmus University Medical Center, Erasmus University Rotterdam The Netherlands

6. Department of Cardiology University Medical Center Groningen, University of Groningen Groningen The Netherlands

7. Institute of Cardiovascular Science, Faculty of Population Health Sciences University College London London UK

8. Health Data Research UK and Institute of Health Informatics University College London London UK

Funder

ZonMw

Hartstichting

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14073

Reference35 articles.

1. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

2. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

3. New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy

4. Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death

5. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of nutritional interventions on cancer patients receiving neoadjuvant chemoradiotherapy: a meta-analysis of randomized controlled trials;Supportive Care in Cancer;2024-08-10

2. Association of liver fibrosis‐4 index with adverse outcomes in hypertrophic cardiomyopathy patients;ESC Heart Failure;2024-07-24

3. Characterization of clinical serum cardiac biomarker levels in individuals with Friedreich ataxia;Journal of the Neurological Sciences;2024-06

4. Identification and validation of pyroptosis-related genes as potential biomarkers for hypertrophic cardiomyopathy: A comprehensive bioinformatics analysis;Medicine;2024-01-26

5. Diretriz sobre Diagnóstico e Tratamento da Cardiomiopatia Hipertrófica – 2024;Arquivos Brasileiros de Cardiologia;2024